COVID vaccines contain 36-627x more DNA than allowed, plus mRNA vaccines now target 8 different diseases

Key Findings

🎯 New peptide codes enable organ-specific mRNA delivery beyond the liver

• Scientists developed "POST codes" - specific amino acid sequences that direct mRNA-loaded nanoparticles to different organs after injection

• The system works by creating specific protein coronas around nanoparticles that target particular tissues

• This breakthrough could enable mRNA therapies for diseases affecting the brain, heart, lungs, and other organs currently difficult to target

🔬 CRISPR gene editing delivered by mRNA shows 2.5x better DNA repair

• Researchers combined two delivery technologies to create CRISPR LNP-SNAs that showed 2-3 fold higher cellular uptake than standard lipid nanoparticles

• The hybrid system achieved 21 ± 7% efficiency for precise DNA repair (homology-directed repair) compared to 8 ± 4% with regular LNPs

• The approach also reduced cell toxicity while improving gene transfection across multiple cell types and genetic targets

💡 Pfizer COVID vaccine effectiveness drops to just 8% after 11 months in teens

• Danish study of 471,272 adolescents (235,636 vaccinated, 235,636 unvaccinated) tracked vaccine effectiveness over nearly a year

• Protection against mild COVID dropped from 43% at 25 days to 8-8.4% at 320 days post-vaccination

• Protection against hospitalization fell from 54% to 22% over the same period, with only 5 severe cases in vaccinated vs 14 in unvaccinated teens

🧪 mRNA cancer vaccine eliminates 97% of eye cancer cells while sparing healthy tissue

• Researchers used CRISPR-Cas13d delivered by mRNA to target RASGRP3, a gene essential for uveal melanoma survival but not needed by healthy cells

• The treatment eliminated >97% of uveal melanoma cells while leaving retinal pigment cells unharmed

• This RNA-targeting approach worked better than conventional CRISPR-Cas9 or siRNA methods without causing permanent genetic changes

🎯 Light-controlled mRNA delivery enables precise tumor treatment

• Scientists developed LITS (Light-Induced Transfection System) that delivers mRNA systemically but only activates protein production where light is applied

• Using IL-2 as a test case, the system triggered strong anti-tumor immune responses in light-exposed tumors while maintaining safe levels in other tissues

• The approach eliminated lung metastases in a breast cancer model by optimizing light exposure to drive immunogenic cell death

🔬 New mRNA influenza vaccine protects against both H1N1 and influenza B in mice

• Researchers designed three mRNA vaccines using influenza nucleoprotein, with the most effective version (Ub-Re-N) enhanced with ubiquitin modification

• The Ub-Re-N vaccine triggered strong T-cell responses without producing antibodies, providing broad protection against multiple flu strains

• Mice depleted of CD8+ T cells lost most protection, confirming the vaccine works through cellular immunity rather than traditional antibody responses